- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/18 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 241/18
Total number of patents in this class: 321
10-year publication summary
|
13
|
21
|
32
|
32
|
24
|
23
|
22
|
17
|
10
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10849 |
9 |
| Sumitomo Chemical Company, Limited | 9046 |
9 |
| Inflazome Limited | 85 |
9 |
| Amgen Inc. | 4074 |
8 |
| BASF SE | 20933 |
7 |
| Gilead Sciences, Inc. | 2036 |
7 |
| Centre National de La Recherche Scientifique | 10418 |
6 |
| Abbvie Inc. | 1800 |
6 |
| Calico Life Sciences LLC | 96 |
6 |
| F. Hoffmann-La Roche AG | 7925 |
5 |
| Merck Patent GmbH | 5831 |
5 |
| Ardea Biosciences, Inc. | 72 |
5 |
| Dart NeuroScience, LLC | 49 |
5 |
| Lario Therapeutics Ltd | 13 |
5 |
| President and Fellows of Harvard College | 5976 |
4 |
| Raqualia Pharma Inc. | 122 |
4 |
| Revolution Medicines, Inc. | 234 |
4 |
| Universite de Montpellier | 985 |
4 |
| Sanofi | 4055 |
4 |
| LG Chem, Ltd. | 17632 |
3 |
| Other owners | 206 |